New advances in the therapy of non-cystic fibrosis bronchiectasis

Fuente: Redalyc
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: A. Amorim
Format: Artículo científico
Sprache:en
Veröffentlicht: Sociedade Portuguesa de Pneumologia 2013
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1876472449347878912
author A. Amorim
author_facet A. Amorim
contents New advances in the therapy of non-cystic fibrosis bronchiectasis A. Amorim F. Gamboa P. Azevedo Medicina Non Anti Therapy Advances Mucoactive Non-cystic fibrosis bronchiectasis remains a common and important respiratory dis- ease to date. It is a chronic pathology and consequently the patients usually require continuous treatment. In recent decades therapies that do not have scientific evidence of their benefits have been commonly used in non-cystic fibrosis bronchiectasis. Cystic fibrosis has provided the experience to extrapolate therapeutic approaches to other bronchiectasis patients. Finally, in the last few years some trials have been carried out specifically in non-cystic fibrosis bronchiectasis which aim to assess the efficacy of some of the treatments which are commonly used but sometimes without clear indication. This review will discuss the recent results from these trials, namely mucoactive, anti- inflammatory and antibiotic therapy. Several trials are ongoing and we hope they will be able to add clarification to the management of these patients. 2013 artículo científico 0873-2159 https://www.redalyc.org/articulo.oa?id=169728915006 en http://www.redalyc.org/revista.oa?id=1697 Revista Portuguesa de Pneumología application/pdf Sociedade Portuguesa de Pneumologia Revista Portuguesa de Pneumología (Portugal) Num.6 Vol.19
format Artículo científico
id redalyc_169728915006
institution Redalyc
language en
publishDate 2013
publisher Sociedade Portuguesa de Pneumologia
spellingShingle New advances in the therapy of non-cystic fibrosis bronchiectasis
A. Amorim
Medicina
Non
Anti
Therapy
Advances
Mucoactive
New advances in the therapy of non-cystic fibrosis bronchiectasis A. Amorim F. Gamboa P. Azevedo Medicina Non Anti Therapy Advances Mucoactive Non-cystic fibrosis bronchiectasis remains a common and important respiratory dis- ease to date. It is a chronic pathology and consequently the patients usually require continuous treatment. In recent decades therapies that do not have scientific evidence of their benefits have been commonly used in non-cystic fibrosis bronchiectasis. Cystic fibrosis has provided the experience to extrapolate therapeutic approaches to other bronchiectasis patients. Finally, in the last few years some trials have been carried out specifically in non-cystic fibrosis bronchiectasis which aim to assess the efficacy of some of the treatments which are commonly used but sometimes without clear indication. This review will discuss the recent results from these trials, namely mucoactive, anti- inflammatory and antibiotic therapy. Several trials are ongoing and we hope they will be able to add clarification to the management of these patients. 2013 artículo científico 0873-2159 https://www.redalyc.org/articulo.oa?id=169728915006 en http://www.redalyc.org/revista.oa?id=1697 Revista Portuguesa de Pneumología application/pdf Sociedade Portuguesa de Pneumologia Revista Portuguesa de Pneumología (Portugal) Num.6 Vol.19
title New advances in the therapy of non-cystic fibrosis bronchiectasis
topic Medicina
Non
Anti
Therapy
Advances
Mucoactive
url https://www.redalyc.org/articulo.oa?id=169728915006